​

Alto Neuroscience (ANRO) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

ANRO Stock Forecast

Alto Neuroscience (ANRO) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $22.00, with a high of $28.00 and a low of $16.00. This represents a 12.82% increase from the last price of $19.50.

- $6 $12 $18 $24 $30 High: $28 Avg: $22 Low: $16 Last Closed Price: $19.5

ANRO Stock Rating

Alto Neuroscience stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

ANRO Price Target Upside V Benchmarks

TypeNameUpside
StockAlto Neuroscience12.82%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$28.00$28.00$22.00
Last Closing Price$19.50$19.50$19.50
Upside/Downside43.59%43.59%12.82%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26-91--10
Jan, 26-91--10
Dec, 25-91--10
Nov, 25171--9
Oct, 25171--9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 17, 2026Thomas ShraderBTIG$28.00$16.8965.78%43.59%
Oct 20, 2025Robert W. Baird$16.00$11.0744.53%-17.95%
Oct 23, 2024Brian SkorneyRobert W. Baird$10.00$14.53-31.18%-48.72%
Jun 20, 2024Brian SkorneyRobert W. Baird$32.00$11.11188.03%64.10%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 17, 2026BTIGBuyBuyhold
Oct 23, 2024WedbushOutperformNeutraldowngrade
Oct 23, 2024Rodman & RenshawBuyNeutraldowngrade
Sep 10, 2024Cowen & Co.BuyBuyhold
Sep 03, 2024WedbushOutperforminitialise
Jun 20, 2024Rodman & RenshawBuyinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.35$-2.50----
Avg Forecast$-2.93$-2.59$-2.53$-2.73$-2.52$-2.80
High Forecast$-2.93$-2.41$-2.24$-2.22$-2.23$-2.80
Low Forecast$-2.93$-2.75$-2.95$-3.38$-2.67$-2.80
Surprise %-53.92%-3.47%----

Revenue Forecast

$2M $4M $5M $7M $9M $11M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast----$10.02M$2.27M
High Forecast----$10.02M$2.27M
Low Forecast----$10.02M$2.27M
Surprise %------

Net Income Forecast

$-95M $-83M $-71M $-59M $-47M $-35M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-36.30M$-61.43M----
Avg Forecast$-78.64M$-69.39M$-77.05M$-75.32M$-65.84M$-75.21M
High Forecast$-78.64M$-64.87M$-60.12M$-59.78M$-59.90M$-75.21M
Low Forecast$-78.64M$-73.90M$-79.21M$-90.86M$-71.77M$-75.21M
Surprise %-53.83%-11.47%----

ANRO Forecast FAQ

Is Alto Neuroscience stock a buy?

Alto Neuroscience stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Alto Neuroscience is a favorable investment for most analysts.

What is Alto Neuroscience's price target?

Alto Neuroscience's price target, set by 7 Wall Street analysts, averages $22 over the next 12 months. The price target range spans from $16 at the low end to $28 at the high end, suggesting a potential 12.82% change from the previous closing price of $19.5.

How does Alto Neuroscience stock forecast compare to its benchmarks?

Alto Neuroscience's stock forecast shows a 12.82% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Alto Neuroscience over the past three months?

  • February 2026: 0% Strong Buy, 90.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 90.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 90.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.

What is Alto Neuroscience’s EPS forecast?

Alto Neuroscience's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.53, marking a 1.20% increase from the reported $-2.5 in 2024. Estimates for the following years are $-2.73 in 2026, $-2.52 in 2027, and $-2.8 in 2028.

What is Alto Neuroscience’s revenue forecast?

Alto Neuroscience's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $10.02M for 2027, and $2.27M for 2028.

What is Alto Neuroscience’s net income forecast?

Alto Neuroscience's net income forecast for the fiscal year ending in December 2025 stands at $-77.05M, representing an 25.42% increase from the reported $-61.431M in 2024. Projections indicate $-75.319M in 2026, $-65.835M in 2027, and $-75.208M in 2028.